Literature DB >> 28546251

MR Imaging in Sudden Sensorineural Hearing Loss. Time to Talk.

G Conte1, F Di Berardino2, C Sina3, D Zanetti2, E Scola3, C Gavagna3, L Gaini4, G Palumbo5, P Capaccio4, F Triulzi3,6.   

Abstract

Sudden sensorineural hearing loss is defined as acute hearing loss of the sensorineural type of at least 30 dB over 3 contiguous frequencies that occurs within a 72-hour period. Although many different causative factors have been proposed, sudden sensorineural hearing loss is still considered "idiopathic" in 71%-85% of cases, and treatments are empiric, not based on etiology. MR imaging implemented with a 3D FLAIR sequence has provided new insights into the etiology of sudden sensorineural hearing loss. Herein, we review the current management trends for patients with sudden sensorineural hearing loss, from the initial clinical diagnosis to therapeutic strategies and diagnostic work-up. We focused primarily on MR imaging assessment and discuss the relevance that MR imaging findings might have for patient management, pointing out different perspectives for future clinical research.
© 2017 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2017        PMID: 28546251      PMCID: PMC7960407          DOI: 10.3174/ajnr.A5230

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  41 in total

Review 1.  Clinical practice. Idiopathic sudden sensorineural hearing loss.

Authors:  Steven D Rauch
Journal:  N Engl J Med       Date:  2008-08-21       Impact factor: 91.245

2.  Variability in the management of idiopathic sudden sensorineural hearing loss.

Authors:  Daniel H Coelho; Leroy R Thacker; David W Hsu
Journal:  Otolaryngol Head Neck Surg       Date:  2011-06-20       Impact factor: 3.497

Review 3.  Is Gadolinium contrast enhancement necessary in screening MRI for asymmetric sensorineural hearing loss?

Authors:  Marisa Ryan; Jane L Weissman; David Kaylie
Journal:  Laryngoscope       Date:  2014-08-11       Impact factor: 3.325

4.  T1 pseudohyperintensity on fat-suppressed magnetic resonance imaging: a potential diagnostic pitfall.

Authors:  Tuan N Huynh; Thor Johnson; Liina Poder; Bonnie N Joe; Emily M Webb; Fergus V Coakley
Journal:  J Comput Assist Tomogr       Date:  2011 Jul-Aug       Impact factor: 1.826

5.  Revisiting the relationship of three-dimensional fluid attenuation inversion recovery imaging and hearing outcomes in adults with idiopathic unilateral sudden sensorineural hearing loss.

Authors:  Wen-Huei Liao; Hsiu-Mei Wu; Hung-Yi Wu; Tzong-Yang Tu; An-Suey Shiao; Mauricio Castillo; Sheng-Che Hung
Journal:  Eur J Radiol       Date:  2016-10-15       Impact factor: 3.528

Review 6.  Antivirals for idiopathic sudden sensorineural hearing loss.

Authors:  Zaid Awad; Charlie Huins; David D Pothier
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 7.  Controversies in the management of sudden sensorineural hearing loss: an evidence-based review.

Authors:  R Lawrence; R Thevasagayam
Journal:  Clin Otolaryngol       Date:  2015-06       Impact factor: 2.597

8.  The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study.

Authors:  W R Wilson; F M Byl; N Laird
Journal:  Arch Otolaryngol       Date:  1980-12

9.  Evaluation of Compliance for Treatment of Sudden Hearing Loss: A CHEER Network Study.

Authors:  David L Witsell; Tawfiq Khoury; Kristine A Schulz; Robert Stachler; Debara L Tucci; Daniel Wojdyla
Journal:  Otolaryngol Head Neck Surg       Date:  2016-07       Impact factor: 3.497

10.  Magnetic resonance imaging in sudden deafness.

Authors:  Hugo Valter Lisboa Ramos; Flávia Alencar Barros; Hélio Yamashita; Norma de Oliveira Penido; Ana Cláudia Valério de Souza; Wellington Yugo Yamaoka
Journal:  Braz J Otorhinolaryngol       Date:  2005-12-15
View more
  1 in total

1.  Injected 3T-3D-FLAIR-MRI labyrinthine patterns match with the severity and tonotopic alteration in sudden sensorineural hearing loss.

Authors:  L Compagnone; V Levigne; B Pereira; L Boyer; T Mom; S Mirafzal
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-14       Impact factor: 3.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.